CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast

Journal of Clinical Pathology

Volumn 52, Issue 11, 1999, Pages 862-864

  Saddik, Maruf ^a   Lai, Raymond ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

CD44s; Intraductal papilloma; Papillary carcinoma of breast

Indexed keywords

CD44V ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST PAPILLOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0032696275     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.11.862     Document Type: Article

References (12)

1. Rosen PP, ed. Papillary carcinoma. In: Rosen's breast pathology. Philadelphia: Lippincott-Raven, 1997:335-54.
2. Kraus FT, Neubecker RD. The differential diagnosis of papillary tumors of the breast. Cancer 1962;5:444-55.
3. Rosen PP, Oberman HA, Invasive carcinoma. In: Atlas of tumor pathology: tumors of the mammary gland. Washington DC: Armed Forces Institute of Pathology, 1992:207-19.
4. Price EA, Coombe DR, Murray JC. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer 1996;65:513-18.
5. Gunthert U. CD44 in malignant disorders. Curr Topics Microbiol Immunol 1993;184:271-85.
6. Bankfalvi A, Terpe HJ, Breukelmann D, et al. Gains and losses of CD44 expression during breast carcinogenesis and tumor progression, Histopathology 1998;33:107-16.
7. Regidor PA, Collies R, Regidor M, et al. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. correlation with established prognostic parameters. Arch Gynecol Obstet 1996;258:125-35.
8. Guriec N, Marcellin L, Gairard B, et al. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clin Exp Metastasis 1996; 14:434.
9. Schumacher U, Horny HP, Horst HA, et al. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer. Eur J Surg Oncol 1996;22:259-61.
10. Friedrichs K, Franke F, Lisboa B-W, et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 1995;55:5424-33.
11. Murad TM, Swaid S, Pritchett P. Malignant and benign papillary lesions of the breast. Hum Pathol 1977;8:379-90.
12. Papotti M, Gugliotta P, Eusebi V, et al. Immunohisto-chemical analysis of benign and malignant papillary lesions of the breast. Am J Surg Pathol 1983;7:451-61.